Chinese MMSE
Cross-source consensus on Chinese MMSE from 1 sources and 3 claims.
1 sources · 3 claims
Risks & contraindications
Interactions
Other
Highlighted claims
- The study team had used an unauthorised Chinese MMSE version without permission. — Correction: ‘SinoMAKS—protocol of a randomised controlled trial to evaluate the Chinese version of the non-pharmacological, multimodal MAKS intervention for people with mild to moderate dementia in Chinese nursing homes’
- Researchers using the MMSE, including translated versions such as the Chinese MMSE, must obtain written permission from PAR. — Correction: ‘SinoMAKS—protocol of a randomised controlled trial to evaluate the Chinese version of the non-pharmacological, multimodal MAKS intervention for people with mild to moderate dementia in Chinese nursing homes’
- The MMSE permission issue was rectified with PAR and tied to invoice IN-00565861. — Correction: ‘SinoMAKS—protocol of a randomised controlled trial to evaluate the Chinese version of the non-pharmacological, multimodal MAKS intervention for people with mild to moderate dementia in Chinese nursing homes’